Associations between insulin-like growth factors and their binding proteins and other prognostic indicators in breast cancer

British Journal of Cancer

Volumn 74, Issue 8, 1996, Pages 1242-1247

  Yu, H ^a,b   Levesque, M A ^a,b   Khosravi, M J ^b,c   Papanastasiou Diamandi, A ^c   Clark, G M ^d   Diamandis, E P ^a,b  

^a MOUNT SINAI HOSPITAL   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c Diagnostic Systems Laboratories   (Canada)

^d UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

Author keywords

Breast cancer; Growth factor; Insulin like growth factor binding protein; Prognostic marker; Prostate specific antigen

Indexed keywords

PROSTATE SPECIFIC ANTIGEN; SOMATOMEDIN; SOMATOMEDIN BINDING PROTEIN; SOMATOMEDIN BINDING PROTEIN 3;

ARTICLE; BREAST CANCER; BREAST CARCINOGENESIS; HUMAN; HUMAN TISSUE; PLOIDY; PRIORITY JOURNAL;

EID: 0029827295     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1038/bjc.1996.523     Document Type: Article

References (40)

1. ARTEAGA CL. (1992). Interference of the IGF system as a strategy to inhibit breast cancer growth. Breast Cancer Res. Treat., 22, 101-106.
2. BASERGA R. (1995). The insulin-like growth factor I receptor: a key to tumor growth? Cancer Res., 55, 249-252.
3. CLEMMONS DR, CAMACHO-HUBNER C, CORONADO E AND OSBORNE CK. (1990). Insulin-like growth factor binding protein secretion by breast cancer cell lines: Correlation with estrogen receptor status. Endocrinology, 127, 2679-2686.
4. COHEN P, GRAVES HCB, PEEHL DM, KAMAREI M, GIUDICE LC, AND ROSENFELD RG. (1992). Prostate-specific antigen (PSA) is an insulin-like growth factor binding protein-3 protease found in seminal plasma. J. Clin. Endocrinol. Metab., 75, 1046-1053.
5. COHEN P, PEEHL DM, GRAVES HCB AND ROSENFELD RG. (1994). Biological effects of prostate specific antigen as an insulin-like growth factor binding protein-3 protease. J. Endocrinol., 142, 407-415.
6. CULIG Z, HOBISCH A, CRONAUER MV, RADMAYR C, TRAPMAN J, HITTMAIR A, BARTSCH G AND KLOCKER H. (1994). Androgen receptor activation in prostatic tumor cell lines by insulin-like growth factor-I, keratinocyte growth factor, and epidermal growth factor. Cancer Res., 54, 5474 - 5478.
7. CULLEN KJ, ALLISON A, MARTIRE I, ELLIS M AND SINGER C. (1992). Insulin-like growth factor expression in breast cancer epithelium and stroma. Breast Cancer Res. Treat., 22, 21 - 29.
8. DAUGHADAY WH AND ROTWEIN P. (1989). Insulin-like growth factors I and II. Peptide, messenger ribonucleic acid and gene structure, serum, and tissue concentrations. Endocr. Rev., 10, 68 - 91.
9. DIAMANDIS EP, YU H AND SUTHERLAND DJA. (1994). Detection of prostate-specific antigen immunoreactivity in breast tumors. Breast Cancer Res. Treat., 32, 301 - 310.
10. FIGUEROA JA AND YEE D. (1992). The insulin-like growth factor binding proteins (IGFBPs) in human breast cancer. Breast Cancer Res. Treat., 22, 81-90.
11. FIGUEROA JA, JACKSON JG, MCGUIRE WL, KRYWICKI RF AND YEE D. (1993). Expression of insulin-like growth factor binding proteins in human breast cancer correlations with estrogen receptor status. J. Cell Biochem., 52, 196 - 205.
12. GARGOSKY SE, PHAM HM, WILSON KF, LIU F, GIUDICE LC AND ROSENFELD RG. (1992). Measurement and characterization of insulin-like growth factor binding protein-3 in human biological fluids: discrepancies between radioimmunoassay and ligand blotting. Endocrinology, 131, 3051 - 3060.
13. HUYNH HT, TETENES E, WALLACE L AND POLLAK M. (1993). In vivo inhibition of insulin-like growth factor I gene expression by tamoxifen. Cancer Res., 53, 1727 - 1730.
14. KANETY H, MADJAR Y, DAGAN Y, LEVI J, PAPA MZ, PARIENTE C, GOLDWASSER B AND KARASIK A. (1993). Serum insulin-like growth factor-binding protein-2 (IGFBP-2) is increased and IGFBP-3 is decreased in patients with prostate cancer: correlation with serum prostate-specific antigen. J. Clin. Endocrinol. Metab., 77, 229 - 233.
15. KHOSRAVI MJ, DIAMANDI A, MISTRY J AND LEE PDK. (1996). A non-competitive ELISA for human serum insulin-like growth factor-I. Clin. Chem. (in press).
16. KRYWICKI RF AND YEE D. (1992). The insulin-like growth factor family of ligands, receptors, and binding proteins. Breast Cancer Res. Treat., 22, 7 - 19.
17. LEROITH D, BASERGA R, HELMAN L AND ROBERTS CT. (1995). Insulin-like growth factors and cancer. Ann. Intern. Med., 122, 54 - 59.
18. LEVESQUE MA, CLARK GM, YU H AND DIAMANDIS EP. (1995). Immunofluorometric analysis of p53 protein and prostate specific antigen in breast tumors and their association with other prognostic indicators. Br. J. Cancer, 72, 720 - 727.
19. LONNING PE, HALL K, AAKVAAG A AND LIEN EA. (1992). Influence of tamoxifen on plasma levels of insulin-like growth factor I and insulin-like growth factor binding protein I in breast cancer patients. Cancer Res., 52, 4719 - 4723.
20. MCGUIRE WL AND CLARK GM. (1992). Prognostic factors and treatment decisions in axillary-node-negative breast cancer. N. Engl. J. Med., 326, 1756 - 1761.
21. MCGUIRE WL, TANDON AK, ALLRED DC, CHAMNESS GC AND CLARK GM. (1990). How to use prognostic factors in axillary-node-negative breast cancer patients. J. Natl Cancer Inst., 82, 1006 - 1015.
22. MCGUIRE WL, JACKSON JG, FIGUEROA JA, SHIMASAKI S, POWELL DR AND YEE D. (1992). Regulation of insulin-like growth factor-binding protein (IGFBP) expression by breast cancer cells: use of IGFBP-1 as an inhibitor of insulin-like growth factor action. J. Natl Cancer Inst., 84, 1336 - 1341.
23. MANNI A, BADGER B, WEI L, ZAENGLEIN A, GROVE R, KHIN S, HEITJAN D, SHIMASAKI S AND LING N. (1994). Hormonal regulation of insulin-like growth factor II and insulin-like growth factor binding protein expression by breast cancer cells in vivo: evidence for stromal epithelial interactions. Cancer Res., 54, 2934 - 2942.
24. OH Y, MULLER HL, LAMSON G AND ROSENFELD RG. (1993). Insulin-like growth factor (IGF)-independent action of IGF-binding protein-3 in Hs578T human breast cancer cells. J. Biol. Chem., 268, 14964 - 14971.
25. OWENS PC, GILL PG, DE YOUNG NJ, WEGER MA, KNOWLES SE AND MOYSE KJ. (1993). Estrogen and progesterone regulate secretion of insulin-like growth factor binding proteins by human breast cancer cells. Biochem. Biophys. Res. Commun., 193, 467-473.
26. PAIK S. (1992). Expression of IGF-I and IGF-II mRNA in breast tissue. Breast Cancer Res. Treat., 22, 31 - 38.
27. PEKONEN F, NYMAN T, ILVESMAKI V AND PARTANEN S. (1992). Insulin-like growth factor binding proteins in human breast cancer tissue. Cancer Res., 52, 5204-5207.
28. POLLAK M, CONSTANTINO J, POLYCHRONAKOS C, BLAUER SA, GUYDA H, REDMOND C, FISHER B AND MARGOLESE R. (1990). Effect of tamoxifen on serum insulin-like growth factor I levels in stage I breast cancer patients. J. Natl Cancer Inst., 82, 1693-1697.
29. POLLAK MN, HUYNH HT AND LEFEBVRE SP. (1992). Tamoxifen reduces serum insulin-like growth factor I (IGF-I). Breast Cancer Res. Treat., 22, 91-100.
30. PRATT SE AND POLLAK MN. (1993). Estrogen and antiestrogen modulation of MCF7 human breast cancer cell proliferation is associated with specific alterations in accumulation of insulin-like growth factor-binding proteins in conditioned media. Cancer Res., 53, 5193 - 5198.
31. PRATT SE AND POLLAK MN. (1994). Insulin-like growth factor binding protein 3 (IGF-BP3) inhibits estrogen-stimulated breast cancer cell proliferation. Biochem. Biophys. Res. Commun., 198, 292 - 297.
32. SHEIKH MS, SHAO ZM, CLEMMONS DR, LEROITH D. ROBERTS CT AND FONTANA JA. (1992). Identification of the insulin-like growth factor binding proteins 5 and 6 (IGFBP-5 and 6) in human breast cancer cells. Biochem. Biophys. Res. Commun., 183, 1003-1010.
33. TANDON AK, CLARK GM, CHAMNESS GC, ULLRICH A AND MCGUIRE WL. (1989). HER-2/neu oncogene protein and prognosis in breast cancer. J. Clin. Oncol., 7, 1120-1128.
34. VALENTINIS B, BHALA A, DEANGELIS T, BASERGA R AND COHEN P. (1995). The human insulin-like growth factor (IGF) binding protein-3 inhibits the growth of fibroblasts with a targeted disruption of the IGF-I receptor gene. Mol. Endocrinol., 9, 361 - 367.
35. WINSTON R, KAO PC AND KIANG DT. (1994). Regulation of insulin-like growth factors by antiestrogen. Breast Cancer Res. Treat., 31, 107 - 115.
36. YEE D, FAVONI RE, LIPPMAN ME AND POWELL DR. (1991). Identification of insulin-like growth factor binding proteins in breast cancer cells. Breast Cancer Res. Treat., 18, 3-10.
37. YEE D, SHARMA J AND HILSENBECK SG. (1994). Prognostic significance of insulin-like growth factor-binding protein expression in axillary lymph node-negative breast cancer. J. Natl Cancer Inst., 86, 1785 - 1789.
38. YOUNG CY, MONTGOMERY BT, ANDREWS PE, QUI SD, BILHARTZ DL AND TINDALL DJ. (1991). Hormonal regulation of prostate-specific antigen messenger RNA in human prostatic adenocarcinoma cell line LNCaP. Cancer Res., 51, 3748 - 3752.
39. YU H. DIAMANDIS EP, ZARGHAMI N AND GRASS L. (1994). Induction of prostate specific antigen production by steroid and tamoxifen in breast cancer cell lines. Breast Cancer Res. Treat., 32, 291 - 300.
40. YU H, GIAI M, DIAMANDIS EP, KATSAROS D, SUTHERLAND DJA, LEVESQUE MA, ROAGNA R, PONZONE R AND SISMONDI P. (1995). Prostate-specific antigen is a new favourable prognostic indicator for women with breast cancer. Cancer Res., 55, 2104 - 2110.